Because of extensive research within the anti-aging field and funding by billionaires, numerous scientific startups are on the cusp of delivering age-reversal solutions.
The latest entrant within the biotech world is Altos Labs. Launched earlier this yr, it boasts 4 Nobel prize winners as its board members. With a funding of $3bn, Altos Labs has some high-profile investors like Amazon founder Jeff Bezos.
“Ageing is just not similar to rust accumulating on a automobile, it isn’t just breakdown,” Prof Horvath, certainly one of the reputed academics at Altos labs, told SkyNews. “Fairly, there are processes that could be manipulated, you may tweak it. In certain ways, I interpret aging as a software error.”
Unbelievably, the oldest human to have ever lived was Jeanne Calment, who died aged 122 in France in 1997.
“There aren’t any hard limits imposed by biology or by physics that claims that we will not live higher longer,” Kristen Fortney, CEO of San Francisco-based BioAge Labs, told the outlet. Focused on discerning the markers of aging, BioAge Labs is using large amounts of biobank blood and tissue samples to achieve this.
The corporate has already found a drug goal that slows aging-linked muscle loss in mice.
“There may be a protein called apelin that circulates within the blood, and we saw that middle-aged individuals with higher levels of apelin of their blood were living longer, with higher muscle function and higher cognitive function as they age,” Fortney said, in response to Express.
“So, we gave this drug to actually old mice and we showed that it could improve their muscle function. It helped them run faster of their wheels, it increased their muscle size, it improved their grip strength,” the BioAge Labs CEO added.
All that is left is to mimic the identical leads to older humans, and a trial is underway to this end.
One other participant against the race of time is Salk Institute for Biological Studies, a scientific research institute in California. Scientists on the institute reversed the aging in middle-aged and elderly mice through their experiments and a technique called cell rejuvenation therapy. The method involved the usage of reprogramming molecules that turned back the cells to a younger state.
“We’re elated that we are able to use this approach across the lifespan to decelerate aging in normal animals. The technique is each secure and effective in mice,” Juan Carlos, professor at Salk’s Gene Expression Laboratory, said.
The traction anti-aging is receiving is barely going to grow. In accordance with a report by P&S Intelligence, the worldwide anti-aging market is predicted to see an astronomical rise from the present $191.5 billion to a mind-blowing $421.4 billion by 2030, as per Express.